Evaluation of Ivacaftor in Patients Using Ataluren for Nonsense Mutations

NCT03256799 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1

Enrollment

OTHER

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: Ivacaftor/Ataluren

Sponsor

University of Alabama at Birmingham